Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Abroad (travel likely)Recruiting

Conditions

Antibody Mediated Rejection After Kidney Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nephrology department, Hôpital Pitié Salpêtière, Paris, France
Contact: Study coordinator (Yanis TAMZALI, MD, MsC) · yanis.tamzali@aphp.fr · 01 84 82 82 21
Nephrology department, Tenon hospital, Paris, France
Contact: Study coordinator (Emmanuel ESTEVE) · emmanuel.esteve@aphp.fr · 01 56 01 54 49

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Antibody-Mediated Rejection · Kidney Transplantation · Biopsy-proven Histologic Scores

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Scottsdale, United States